FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1327206 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
3 Buck shot, device Acceptable (foundation metadata concept)
3 Buck shot, device (qualifier value) Preferred (foundation metadata concept)
3 alpha hydroxycholanic acid Acceptable (foundation metadata concept)
3 alpha, 7 alpha, 12 alpha, Trihydroxycholanic acid Acceptable (foundation metadata concept)
3 alpha, 7 beta dihydroxy-5 beta cholanic acid Acceptable (foundation metadata concept)
3 alpha,12 alpha, dihydroxycholanic acid Acceptable (foundation metadata concept)
3 alpha,7 alpha, dihydroxycholanic acid Acceptable (foundation metadata concept)
3 antigen Hepatitis B recombinant surface only vaccine product Preferred (foundation metadata concept)
3 beta-HSD deficiency Acceptable (foundation metadata concept)
3 beta-Hydroxysteroid dehydrogenase deficiency Preferred (foundation metadata concept)
3 beta-Hydroxysteroid dehydrogenase deficiency (disorder) Preferred (foundation metadata concept)
3 day faecal fat estimation Preferred (foundation metadata concept)
3 day faecal fat estimation Acceptable (foundation metadata concept)
3 day faecal fat estimation (& level) Preferred (foundation metadata concept)
3 day faecal fat estimation (& level) Preferred (foundation metadata concept)
3 day faecal fat estimation (& level) (procedure) Preferred (foundation metadata concept)
3 day faecal fat estimation (& level) (procedure) Preferred (foundation metadata concept)
3 day fecal fat estimation (procedure) Preferred (foundation metadata concept)
3 female babies Acceptable (foundation metadata concept)
3 hourly Acceptable (foundation metadata concept)
3 hours post-dose Preferred (foundation metadata concept)
3 hours post-dose (qualifier value) Preferred (foundation metadata concept)
3 lead electrocardiographic monitoring Preferred (foundation metadata concept)
3 lead electrocardiographic monitoring (procedure) Preferred (foundation metadata concept)
3 level of presenting part in relation to ischial spines Preferred (foundation metadata concept)
3 level of presenting part in relation to ischial spines (finding) Preferred (foundation metadata concept)
3 male babies Acceptable (foundation metadata concept)
3 methoxy 4 hydroxy phenethylamine Acceptable (foundation metadata concept)
3 methoxy 4 hydroxyphenethylamine Acceptable (foundation metadata concept)
3 methoxy 4 hydroxyphenylethylamine Acceptable (foundation metadata concept)
3 methoxydopamine Acceptable (foundation metadata concept)
3 o'clock position Preferred (foundation metadata concept)
3 o'clock position (qualifier value) Preferred (foundation metadata concept)
3 o'clock position on mammogram Preferred (foundation metadata concept)
3 o'clock position on mammogram (finding) Preferred (foundation metadata concept)
3 part fracture Preferred (foundation metadata concept)
3 part fracture (morphologic abnormality) Preferred (foundation metadata concept)
3 pin head fixation device Preferred (foundation metadata concept)
3 pin head fixation device (physical object) Preferred (foundation metadata concept)
3 point swing through gait Preferred (foundation metadata concept)
3 point swing through gait (finding) Preferred (foundation metadata concept)
3 point swing to gait Preferred (foundation metadata concept)
3 point swing to gait (finding) Preferred (foundation metadata concept)
3 serotype Preferred (foundation metadata concept)
3 serotype (qualifier value) Preferred (foundation metadata concept)
3 serotypes Acceptable (foundation metadata concept)
3 times a day, before meals Acceptable (foundation metadata concept)
3 times a day, with meals Acceptable (foundation metadata concept)
3 to 4 times a day Acceptable (foundation metadata concept)
3 toed sloth Acceptable (foundation metadata concept)
3% Acetic acid Preferred (foundation metadata concept)
3% Acetic acid (substance) Preferred (foundation metadata concept)
3',5'-cyclic AMP synthetase Acceptable (foundation metadata concept)
3',5'-cyclic-GMP phosphodiesterase Preferred (foundation metadata concept)
3',5'-cyclic-guanosine monophosphate phosphodiesterase Acceptable (foundation metadata concept)
3',5'-cyclic-guanosine monophosphate phosphodiesterase (substance) Preferred (foundation metadata concept)
3',5'-cyclic-nucleotide phosphodiesterase Preferred (foundation metadata concept)
3',5'-cyclic-nucleotide phosphodiesterase (substance) Preferred (foundation metadata concept)
3',5'-cyclic-nucleotide phosphodiesterase inhibitor Preferred (foundation metadata concept)
3',5'-cyclic-nucleotide phosphodiesterase inhibitor Preferred (foundation metadata concept)
3',5'-cyclic-nucleotide phosphodiesterase inhibitor (disposition) Preferred (foundation metadata concept)
3',5'-cyclic-nucleotide phosphodiesterase inhibitor-containing product Preferred (foundation metadata concept)
3'-deoxyadenosine Preferred (foundation metadata concept)
3'-deoxyadenosine (substance) Preferred (foundation metadata concept)
3'-deoxyadenosine only product Preferred (foundation metadata concept)
3'-deoxyadenosine-containing product Preferred (foundation metadata concept)
3'-deoxynucleotidase Acceptable (foundation metadata concept)
3'-exonuclease Acceptable (foundation metadata concept)
3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase Preferred (foundation metadata concept)
3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase (substance) Preferred (foundation metadata concept)
3'-methylphthalanilic acid Acceptable (foundation metadata concept)
3'-nucleotidase Preferred (foundation metadata concept)
3'-nucleotidase (substance) Preferred (foundation metadata concept)
3'-phosphoadenylylsulfate 3'-phosphatase Preferred (foundation metadata concept)
3'-phosphoadenylylsulfate 3'-phosphatase (substance) Preferred (foundation metadata concept)
3'-phosphoadenylylsulphate 3'-phosphatase Acceptable (foundation metadata concept)
3'5'-cyclic-CMP synthase Acceptable (foundation metadata concept)
3(or 17)-alpha-hydroxysteroid dehydrogenase Preferred (foundation metadata concept)
3(or 17)-alpha-hydroxysteroid dehydrogenase (substance) Preferred (foundation metadata concept)
3+ pitting edema (finding) Preferred (foundation metadata concept)
3+ pitting oedema Preferred (foundation metadata concept)
3,3' 5 triiodothyronine Acceptable (foundation metadata concept)
3,3' T>2< Acceptable (foundation metadata concept)
3,3' diiodothyronine Preferred (foundation metadata concept)
3,3' diiodothyronine (substance) Preferred (foundation metadata concept)
3,3'-diiodothyronine level above reference range Preferred (foundation metadata concept)
3,3'-diiodothyronine level above reference range (finding) Preferred (foundation metadata concept)
3,3'-diiodothyronine level below reference range Preferred (foundation metadata concept)
3,3'-diiodothyronine level below reference range (finding) Preferred (foundation metadata concept)
3,3'-diiodothyronine within reference range Preferred (foundation metadata concept)
3,3'-diiodothyronine within reference range (finding) Preferred (foundation metadata concept)
3,3'-dimethoxybenzidine Preferred (foundation metadata concept)
3,3'-dimethoxybenzidine (substance) Preferred (foundation metadata concept)
3,3-diphosphono-1,2-propanodicarboxylic acid Preferred (foundation metadata concept)
3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) Acceptable (foundation metadata concept)
3,3-diphosphono-1,2-propanodicarboxylic acid (substance) Preferred (foundation metadata concept)
3,4 Methylhippurate Preferred (foundation metadata concept)
3,4 Methylhippurate (substance) Preferred (foundation metadata concept)
3,4,5-trihydroxybenzoic acid Preferred (foundation metadata concept)
3,4,5-trihydroxybenzoic acid (substance) Preferred (foundation metadata concept)
3,4-Dihydroxyphenylalanine Acceptable (foundation metadata concept)

Start Previous Page 100 of 13273 Next End


Reference Sets

Reference set descriptor

Back to Start